Cosmos Pharmaceutical Corp
TSE:3349
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cosmos Pharmaceutical Corp
Total Current Liabilities
Cosmos Pharmaceutical Corp
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Total Current Liabilities
¥229.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Sundrug Co Ltd
TSE:9989
|
Total Current Liabilities
¥137.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
Tsuruha Holdings Inc
TSE:3391
|
Total Current Liabilities
¥547.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
31%
|
CAGR 10-Years
21%
|
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Total Current Liabilities
¥299B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Total Current Liabilities
¥231.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Total Current Liabilities
¥175.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
Cosmos Pharmaceutical Corp
Glance View
In the bustling landscape of Japan's healthcare and beauty industry, Cosmos Pharmaceutical Corp. stands out as a compelling story of strategic ambition and adaptive growth. Established in 1976, the company emerged in Fukuoka, swiftly evolving from a traditional pharmacy into one of the country's most recognized chains of drugstores. Cosmos carved its niche by blending the conveniences of modern retailing with a diverse array of pharmaceutical, health, and personal care products. It's not merely a matter of selling medication; Cosmos transformed the drugstore experience, offering a comprehensive range of products including cosmetics, daily essentials, and food items, which cater to the holistic needs of its customers. This diversification strategy bolsters revenue streams and mitigates risks associated with dependency on any single product category. The company's financial success is further driven by its efficient use of technology and economy of scale. Cosmos Pharmaceutical masterfully implements IT solutions and logistics optimization to manage its expansive network of stores, which number in the thousands across Japan. This not only reduces operational costs but also ensures timely restocking, enhancing consumer satisfaction. The chain's "Everyday Low Pricing" strategy is pivotal to its profitability, drawing in cost-conscious customers and fostering high sales volume. By maintaining streamlined operations and a customer-centric approach, Cosmos cultivates a symbiotic relationship between growth and efficiency, allowing it to thrive in a competitive market and continue its expansion across Japan.
See Also
What is Cosmos Pharmaceutical Corp's Total Current Liabilities?
Total Current Liabilities
229.4B
JPY
Based on the financial report for Feb 28, 2026, Cosmos Pharmaceutical Corp's Total Current Liabilities amounts to 229.4B JPY.
What is Cosmos Pharmaceutical Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
10%
Over the last year, the Total Current Liabilities growth was 17%. The average annual Total Current Liabilities growth rates for Cosmos Pharmaceutical Corp have been 12% over the past three years , 10% over the past five years , and 10% over the past ten years .